Poland· PL-100058462

Rivanol 0,1%

A ethacridine lactate product containing ethacridini lactas, registered in Poland by Poznańskie Zakłady Zielarskie "Herbapol" S.A..

ATC D08AA01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedRivanol 0,1%ATCD08AA01REGISTER NO.PL-100058462PACKS LISTED12CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Ethacridini lactas
Manufacturer
Poznańskie Zakłady Zielarskie "Herbapol" S.A.
Country
Poland (PL)
ATC code
D08AA01
ATC class
Ethacridine lactate
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 12

  • gtin
    05909990324057
  • gtin
    05909990324019
  • gtin
    05909990324026
  • gtin
    05909990324033
  • gtin
    05909990324040
  • gtin
    05909990324088
  • gtin
    05909990324095
  • gtin
    05909990324101
  • gtin
    05909990324064
  • gtin
    05909990324071
  • gtin
    05909991420826
  • gtin
    05909991420833

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ethacridine lactate in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ethacridine lactate products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Bulgaria · Риванол, Риванолов
  • Germany · Rivanol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8b23a662-374f-48cb-a6e4-dee98e718d7c
GET /v1/drugs/8b23a662-374f-48cb-a6e4-dee98e718d7c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Płyn na skórę",
  "source": "urpl",
  "strength": "1 mg/g",
  "packaging": "05909990324057 ¦ OTC ¦ 8712\n1 butelka 150 g\n05909990324019 ¦ OTC ¦ Skasowane ¦ 14969\n1 op. 10 g\n05909990324026 ¦ OTC ¦ Skasowane ¦ 14970\n1 op. 35 g\n05909990324033 ¦ OTC ¦ 14971\n1 butelka 50 g\n05909990324040 ¦ OTC ¦ 14972\n1 butelka 100 g\n05909990324088 ¦ OTC ¦ 14973\n1 butelka 500 g\n05909990324095 ¦ OTC ¦ 14974\n1 butelka 1000 g\n05909990324101 ¦ Lz ¦ Skasowane ¦ 14975\n1 op. 5 kg\n05909990324064 ¦ OTC ¦ 56705\n1 butelka 200 g\n05909990324071 ¦ OTC ¦ 56706\n1 butelka 250 g\n05909991420826 ¦ OTC ¦ 134958\n1 butelka 90 g\n05909991420833 ¦ OTC ¦ 134959\n1 butelka 140 g",
  "substance": "Ethacridini lactas 0.1 g",
  "common_name": "Ethacridini lactas",
  "pl_product_id": "100058462",
  "pozwolenie_nr": "03240",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about ethacridine lactate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.